Telomir Pharmaceuticals, Inc. Common Stock (TELO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Telomir Pharmaceuticals, Inc. Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | -4.04x | -7.36x | -15.86x | -242.66x | -1500.52x |
| P/B Ratio | 7.12x | 189.26x | 60.28x | -221.14x | -2493.28x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | |||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | |||||
| Current Ratio | 5.14x | 1.94x | 0.33x | 0.05x | 0.00x |
| Quick Ratio | 5.14x | 1.94x | 0.33x | 0.05x | 0.00x |
| Leverage | |||||
| Debt/Equity | 0.00x | 0.15x | 0.03x | -0.62x | 0.00x |
YoY = year-over-year change. Source: FMP..